Literature DB >> 18543087

Techniques to develop and characterize nanosized formulation for salbutamol sulfate.

F J Ahmad, R K Khar, S Sultana, A Bhatnagar.   

Abstract

The present study relates to enhancing the dosing efficiency of pharmaceutical dry powder formulations administered by pulmonary inhalation. In particular, the study relates to the provision of dry powder inhalers (DPI) by forming nanosized particles of salbutamol sulfate (SBM) in order to augment the drug penetrability and deposition in the lungs. SBM, an antiasthmatic was selected to be developed into a nanosized formulation by different techniques like solvation, high-pressure homogenization, and spray drying, which were then compared on the basis of particle shape, particle size, and particle size distribution. In case of solvation method the nanosuspension was prepared by dispersing SBM into a nonsolvent and adding Tween-80 as a surfactant to prevent the agglomeration, the particles obtained therein were in the range of 2-10 mu. The second attempt was made by passing the suspension of SBM through high-pressure homogenizer at 10,000-15,000 psi. A treatment of six cycles of homogenization in presence of a Tween-80 as surfactant was found to give a nanosuspension within a size range 50-100 nm. The only drawback seemed with this technique was the low-product yield and high-processing time (3-4 h). In order to overcome this drawback spray-drying technique was further explored; the solution of SBM containing Tween-80 was stirred on magnetic stirrer at 1,200 rpm and finally dried by using spray dryer at an inlet and outlet temperature of 75 degrees C and 56 degrees C, respectively. The feed rate for spray dryer was kept to be 91 ml/h. The sample was collected and analyzed for particle size distribution which was found to be in the range of 50-100 nm. Keeping in view the positive outcomes in terms of higher yield and lower processing time, the spray-drying technique was taken to give the optimized formulation. Nanosized particles, thus obtained were evaluated for particle size, surface topology and particles size distribution, by Transmission Electron Microscopy (TEM), Scanning Electron Microscopy (SEM), and Quasi-elastic light scattering (QELS) technique, respectively. The nanosized particles were subjected to investigate changes on the physical stability of the powder, for this different analytical method was used as: Fourier transform infrared spectroscopy (FT-IR), Differential Scanning Calorimetry (DSC) and X-ray diffraction (XRD) analysis and thus the result indicates that there was no physical disparity when compared with the commercial SBM sample.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18543087     DOI: 10.1007/s10856-008-3483-5

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  7 in total

1.  Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation.

Authors:  K P Krause; R H Müller
Journal:  Int J Pharm       Date:  2001-02-19       Impact factor: 5.875

Review 2.  Nanosizing: a formulation approach for poorly-water-soluble compounds.

Authors:  Elaine Merisko-Liversidge; Gary G Liversidge; Eugene R Cooper
Journal:  Eur J Pharm Sci       Date:  2003-02       Impact factor: 4.384

3.  Validation of a chiral HPLC assay for (R)-salbutamol sulfate.

Authors:  Alejandra Halabi; Carlos Ferrayoli; Marcela Palacio; Viviana Dabbene; Sara Palacios
Journal:  J Pharm Biomed Anal       Date:  2004-01-27       Impact factor: 3.935

4.  Enhanced drug dissolution using evaporative precipitation into aqueous solution.

Authors:  Marazban Sarkari; Judith Brown; Xiaoxia Chen; Steve Swinnea; Robert O Williams; Keith P Johnston
Journal:  Int J Pharm       Date:  2002-08-28       Impact factor: 5.875

5.  Recent advances in the liquid-phase syntheses of inorganic nanoparticles.

Authors:  Brian L Cushing; Vladimir L Kolesnichenko; Charles J O'Connor
Journal:  Chem Rev       Date:  2004-09       Impact factor: 60.622

6.  Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying.

Authors:  Jessica Elversson; Anna Millqvist-Fureby; Göran Alderborn; Ulla Elofsson
Journal:  J Pharm Sci       Date:  2003-04       Impact factor: 3.534

7.  Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing".

Authors:  P M Young; D Cocconi; P Colombo; R Bettini; R Price; D F Steele; M J Tobyn
Journal:  J Pharm Pharmacol       Date:  2002-10       Impact factor: 3.765

  7 in total
  4 in total

1.  Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent.

Authors:  Nashwa El-Gendy; Kristin L Aillon; Cory Berkland
Journal:  Int J Pharm       Date:  2010-03-07       Impact factor: 5.875

2.  Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols.

Authors:  Nashwa El-Gendy; Warangkana Pornputtapitak; Cory Berkland
Journal:  Eur J Pharm Sci       Date:  2011-09-21       Impact factor: 4.384

3.  Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration.

Authors:  Nashwa El-Gendy; Cory Berkland
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

Review 4.  Nanocrystals based pulmonary inhalation delivery system: advance and challenge.

Authors:  Pengfei Yue; Weicheng Zhou; Guiting Huang; Fangfang Lei; Yingchong Chen; Zhilin Ma; Liru Chen; Ming Yang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.